Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, Viemed Healthcare, Inc. reported revenue of $270M, up 20.5% year over year. Operating margin was 8.5% and net margin 5.5%, on a free-cash-flow margin of 4.4% with capital expenditure at 14.8% of revenue. Every figure is computed directly from VMD's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $270M | 8.5% | 5.5% |
| FY2024 | $224M | 8.0% | 5.0% |
| FY2023 | $183M | 7.8% | 5.6% |
| FY2022 | $139M | 5.9% | 4.5% |
| FY2021 | $117M | 9.9% | 7.8% |
How does VMD compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AACG · ABSI · ACCS · ACHC · ACM · ADUS
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.